SCHEMBL2364757

SCHEMBL2364757

O=C(COC(=O)C1CCC1)c1ccc(C(=O)O)nc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.50
TSHR P16473 1/20 0.50
MDM2 Q00987 1/20 0.50
P4HA1 P13674 1/20 0.47
MIF P14174 1/20 0.47
P4HTM Q9NXG6 1/20 0.47
ATM Q13315 1/20 0.46
L3MBTL1 Q9Y468 7/20 0.44
KDM4E B2RXH2 2/20 0.44
MAPK1 P28482 1/20 0.44
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
KMT2A Q03164 2/20 0.43
GLA P06280 1/20 0.43
HTT P42858 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
HIF1A Q16665 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
MAPT P10636 1/20 0.40
HCAR3 P49019 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1000357 0.86 MAPK1 (0.54) ALDH1A1TSHRMDM2ATML3MBTL1
SCHEMBL1003197 0.81 MAPK1 (0.56) ALDH1A1TSHRMDM2L3MBTL1KDM4E
SCHEMBL17281354 0.74 ALDH1A1 (0.63) ALDH1A1TSHRMDM2ATML3MBTL1
SCHEMBL2356584 0.73 NPC1 (0.43) ALDH1A1TSHRMDM2ATML3MBTL1
SCHEMBL1004606 0.73 NPC1 (0.48) ALDH1A1TSHRMDM2ATML3MBTL1
SCHEMBL27839079 0.73 RAB9A (0.45) ALDH1A1TSHRMDM2ATML3MBTL1
SCHEMBL16352856 0.72 ALDH1A1 (0.60) ALDH1A1TSHRMDM2ATMNPC1
SCHEMBL15746272 0.72 ALDH1A1 (0.64) ALDH1A1TSHRMDM2ATML3MBTL1
SCHEMBL17212624 0.71 ALDH1A1 (0.63) ALDH1A1TSHRMDM2ATMKDM4E
SCHEMBL15159436 0.70 ALDH1A1 (0.43) ALDH1A1TSHRMDM2ATML3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130030000-A1 PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF PAIN AND OTHER INDICATIONS MERCK SHARP & DOHME CORP. 2013-01-31 US disclosed
EP-2528603-A1 PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF PAIN AND OTHER INDICATONS Merck Sharp & Dohme Corp. (US) 2012-12-05 EP disclosed
WO-2011094209-A1 PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF PAIN AND OTHER INDICATONS MERCK SHARP & DOHME CORP. (US) 2011-08-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130030000-A1 PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF PAIN AND OTHER INDICATIONS FAAH, FAAH2, CNR2 ALDH1A1 1422/4885TSHR 4137/4885MDM2 2353/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.